Health Canada drug identification number

DIN 02496348 — NUBEQA 300 MG

NUBEQA is a tablet of Darolutamide marketed by BAYER INC. The full Darolutamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02496348
Brand name
NUBEQA
Active ingredient
Darolutamide
Strength
300 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
BAYER INC
Health Canada status
MARKETED
Drug class
Androgen receptor inhibitor (anti-androgen)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.